Suchergebnisse - "Follmann, Dean"

PubPharm (159)

1

Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial

enthalten in: Vaccine | 2024

von Gilbert, P. | Fong, Y. | Hejazi, N. | +5

2

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

enthalten in: Nature communications | 2024

von Magaret, C. | Li, L. | deCamp, A. | +47

UpdateOf: Res Sq. 2023 May 31;:. - PMID 37398105

3

Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Follmann, D. | Mateja, A. | Fay, M. | +10

4

Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?

enthalten in: Malaria journal | 2023

von Potter, G. | Callier, V. | Shrestha, B. | +6

UpdateOf: Res Sq. 2023 Sep 22;:. - PMID 37790581

5

Stochastic interventional approach to assessing immune correlates of protection : Application to the COVE messenger RNA-1273 vaccine trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Hejazi, N. | Shen, X. | Carpp, L. | +10

6

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults : a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Dayan, G. | Rouphael, N. | Walsh, S. | +120

7

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults : a phase 3, multi-country study

enthalten in: EClinicalMedicine | 2023

von Dayan, G. | Rouphael, N. | Walsh, S. | +126

8

Cross-direct effects in settings with two mediators

enthalten in: Biostatistics (Oxford, England) | 2023

von Gabriel, E. | Sjölander, A. | Follmann, D. | +1

9

Risk of COVID-19 after natural infection or vaccination

enthalten in: EBioMedicine | 2023

von Rick, A. | Laurens, M. | Huang, Y. | +125

10

A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome

enthalten in: The Journal of clinical investigation | 2023

von McDermott, D. | Velez, D. | Cho, E. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]